Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer’s disease animal model

Aseef H. Ahmed, Gehad M. Subaiea, Aseel Eid, Liya Li, Navindra P. Seeram, Nasser H. Zawia*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Abstract

Accumulating research supports the neuroprotective effects of pomegranate (Punica granatum) juice and extracts against Alzheimer’s disease (AD) but there is limited data available in animal models. Here we investigated the effects of a standardized pomegranate extract (PE) on AD pathology in an aged transgenic AD animal model (R1.40).The mice (age 24-30 months) received either PE (at 100 and 200 mg/kg) or a control solution daily for three weeks, and were evaluated in the Morris water maze and the Y-maze for improvements in spatial long-term and working memory functions. Cortical amyloid-β precursor protein (APP) and amyloid-β (A_) levels, along with other relevant biomarkers for AD, were measured in brain tissues. PE did not improve cognitive performance of the mice, but altered levels and ratio of the A_42 and A_40 peptides which would favor a diminution in AD pathogenesis. Further analysis revealed that this reversal could be the product of the modification of _-secretase enzyme activity, the enzyme involved in the generation of these A_ isoforms. Our findings support a specific anti-amyloidogenic mechanism of a pomegranate extract in this aged AD animal model.

Original languageEnglish
Pages (from-to)834-843
Number of pages10
JournalCurrent Alzheimer Research
Volume11
Issue number9
DOIs
Publication statusPublished - 1 Mar 2014
Externally publishedYes

Keywords

  • Alzheimer’s disease
  • Amyloid-β protein
  • Gamma secretase
  • Polyphenols
  • Pomegranate

Fingerprint

Dive into the research topics of 'Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer’s disease animal model'. Together they form a unique fingerprint.

Cite this